美国2型糖尿病亚型发病前的病理生理风险因素:汇总队列研究
该研究汇总美国四个队列的69,725次观察,纳入9,661名无糖尿病成人,中位随访10年,评估七种生物标志物与2型糖尿病及其亚型发病的关联。结果显示BMI、收缩压、HbA1c、HOMA2-%B、HOMA2-IR和LDL胆固醇与糖尿病独立相关,但关联在各亚型间相似;基于单时间点的模型区分亚型能力有限。
要点
- BMI、收缩压、HbA1c、HOMA2-%B、HOMA2-IR和LDL胆固醇与2型糖尿病发病独立相关。
- eGFR与2型糖尿病发病无独立关联。
- 各生物标志物与不同2型糖尿病亚型的关联相似。
核心结论
- 病理生理生物标志物可前瞻性预测2型糖尿病及其亚型,但单时间点测量无法可靠区分亚型。
研究设计与样本
- 汇总队列研究,分析美国四个队列中9,661名无糖尿病成人的69,725次观察,中位随访10年(范围0-17年)。
- 采用时依Cox模型估计七种生物标志物与2型糖尿病及其亚型发病的风险比,并调整人口学和临床协变量。
主要发现
- BMI每增加1 kg/m2,HR为1.03(95% CI 1.02-1.04)。
- 收缩压每增加10 mmHg,HR为1.09(95% CI 1.05-1.13)。
- HbA1c每增加1%,HR为2.46(95% CI 1.73-3.52)。
- HOMA2-%B每增加10单位,HR为0.89(95% CI 0.87-0.91);HOMA2-IR,HR为1.92(95% CI 1.78-2.07)。
- LDL胆固醇每增加10 mg/dL,HR为1.02(95% CI 1.00-1.04);eGFR每增加10 mL/min/1.73 m2,HR为1.02(95% CI 0.98-1.07),无统计学意义。
临床怎么用
- 在糖尿病发病前,可关注BMI、收缩压、HbA1c、HOMA2-IR、HOMA2-%B和LDL胆固醇等指标以评估风险。
- 单时间点生物标志物测量可能不足以精确区分2型糖尿病亚型,需谨慎用于分型预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Understanding the pathophysiology of type 2 diabetes subtypes (severe insulin-deficient diabetes, severe insulin-resistant diabetes, mild obesity-related diabetes, and mild age-related diabetes) before diagnosis can enable precision prevention. We estimated the associations of seven biomarkers with type 2 diabetes subtypes prior to diagnosis. RESEARCH DESIGN AND METHODS: We analyzed 69,725 observations from 9,661 adults without diabetes (median follow-up 10 years [range 0-17 years]) from four U.S. cohorts. Time-dependent Cox models estimated cause-specific hazard ratios (HRs) of seven pathophysiological biomarkers (BMI [kg/m2], systolic blood pressure [SBP] [per 10 mmHg], HbA1c [%], LDL cholesterol [per 10 mg/dL], homeostatic indices [HOMA2 of β-cell function (HOMA2-%B) (per 10 units) and HOMA2 of insulin resistance (HOMA2-IR)], and estimated glomerular filtration rate [eGFR] [per 10 mL/min/1.73 m2]) with incidence of type 2 diabetes and subtypes, adjusting for demographic and clinical covariates. Model performance was evaluated using participants' first and random visits before last follow-up. RESULTS: Of the pooled cohort, 1,569 individuals developed type 2 diabetes. BMI (HR 1.03 [95% CI 1.02, 1.04]), SBP (HR 1.09 [95% CI 1.05, 1.13]), HbA1c (HR 2.46 [95% CI 1.73, 3.52]), HOMA2-%B (HR 0.89 [95% CI 0.87, 0.91]), HOMA2-IR (HR 1.92 [95% CI 1.78, 2.07]), and LDL cholesterol (HR 1.02 [95% CI 1.00, 1.04]), but not eGFR (HR 1.02 [95% CI 0.98, 1.07]), were independently associated with diabetes. Associations were similar across subtypes. Models based on single time points demonstrated a high C-index (0.81-0.90) but modest F1 scores (0.26-0.51) and varying sensitivity and calibration (slope 0.22-1.24). CONCLUSIONS: Pathophysiological biomarkers were prospectively associated with type 2 diabetes and subtypes, but single-time-point measurements before diagnosis could not reliably distinguish subtypes at diagnosis.
引用
- Guo J, Li Z, Patel SA, et al. Pathophysiological Risk Factors Preceding Incidence of Type 2 Diabetes Subtypes: A Pooled Cohort Study in the United States. Diabetes Care. 2026. PMID: 41649356. doi:10.2337/dc25-2069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。